Industry News
Study shows prostate cancer screening under age of 55 may be of limited value
11/13/2015
Mass prostate cancer (PSA) screening before the age of 55 may not have any benefit over screening starting after the age of 55, according to a new 20 year analysis of 6822 patients, presented at...
Receiving curative lung cancer surgery varies by state
11/13/2015
The likelihood of receiving curative-intent surgery for patients with early-stage non-small cell lung cancer (NSCLC) varies substantially from state to state, according to data presented at the...
Suicide rate significantly higher for patients with head and neck cancer
11/13/2015
Patients with head and neck cancer have more than 3 times the incidence of suicide compared with the general population, with rates highest among patients with cancers of the larynx and...
Snake venom could make surgery safer for patients on blood thinners
11/13/2015
Preventing blood clots with drugs such as heparin has become a common practice for fighting some heart and lung conditions, and for certain surgeries.
In new study, Illinois scientists trace activity of cancer-fighting tomato component
11/13/2015
Years of research in University of Illinois scientist John Erdman's laboratory have demonstrated that lycopene, the bioactive red pigment found in tomatoes, reduces growth of prostate tumors in a...
In conjunction with the Big Ten Cancer Research Consortium (BTCRC), Rutgers Cancer Institute of New Jersey has opened a clinical trial for patients with kidney cancer that has spread to other parts...
What is the role of psychological factors in nausea during cancer therapy?
11/13/2015
A study in Psychotherapy and Psychosomatics sheds new light on the relationship between psychological factors and nausea and vomiting during chemotherapy of cancer.
Cornell engineers develop 'killer cells' to destroy cancer in lymph nodes
11/13/2015
Cornell biomedical engineers have developed specialized white blood cells - dubbed "super natural killer cells" - that seek out cancer cells in lymph nodes with only one purpose: destroy them.
TGen identifies drug that could limit the spread of deadly brain tumors
11/13/2015
Study funded by Ivy Foundation shows PPF could help treat glioblastomas by sensitizing tumors to chemotherapy and radiation treatments.
'No evidence' that bone-growth agent for spinal fusion increases cancer risk
11/13/2015
A new study may alleviate concerns regarding increased cancer risk for patients undergoing spinal fusion surgery with recombinant human bone morphogenetic protein (rhBMP).